NeuLogiq, developed by Cumulus Neuroscience, is a medical-grade, at-home and in-clinic neuro-assessment platform designed to transform CNS clinical trials and brain health monitoring. It combines tablet-based cognitive assessments with a 510(k)-cleared EEG headset, speech and facial expression analysis, and sleep metrics to capture rich, longitudinal data on brain function in real-world settings. Proprietary machine learning analytics running in a secure cloud environment integrate behavioral, physiological, and functional data to detect subtle treatment effects, improve patient stratification, and accelerate development of therapies for brain disorders such as dementia and Alzheimer’s disease.